New cholesterol guidelines and the secondary prevention of cardiovascular disease - a commentary on epistemic aspects.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25128714.
- Also identified by DOI 10.1016/j.ypmed.2014.06.035.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The recommendations contained in the 2013 cholesterol guidelines may be described as either with or without a direct empirical clinical trial basis. Recommendations without a direct empirical clinical trial basis tend to be controversial. Recommendations with and without a direct empirical clinical trial basis are mixed in the same text - while at the same time (rightfully) rejecting previous recommendations, also without a direct empirical clinical trial basis.
Medical subject headings
- Atherosclerosis
- Cholesterol, LDL
- Hydroxymethylglutaryl-CoA Reductase Inhibitors